Rho-GEF Trio Regulates Osteosarcoma Progression and Osteogenic Differentiation Through Rac1 and RhoA

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2021 Dec 11

PMID 34893584

Citations 6

Authors

Junyi Wang

Lichan Yuan

Xiaohong Xu

Zhongyin Zhang

Yuhuan Ma

Leilei Hong

Junqing Ma

Affiliations

Soon will be listed here.

Abstract

Osteosarcoma (OS) is the most common primary bone tumor. Its high mortality rate and metastasis rate seriously threaten human health. Currently, the treatment has reached a plateau, hence we urgently need to explore new therapeutic directions. In this paper, we found that Trio was highly expressed in osteosarcoma than normal tissues and promoted the proliferation, migration, and invasion of osteosarcoma cells. Furthermore, Trio inhibited osteosarcoma cells' osteogenic differentiation in vitro and accelerated the growth of osteosarcoma in vivo. Given Trio contains two GEF domains, which have been reported as the regulators of RhoGTPases, we further discovered that Trio could regulate osteosarcoma progression and osteogenic differentiation through activating RhoGTPases. In summary, all our preliminary results showed that Trio could be a potential target and prognostic marker of osteosarcoma.

Citing Articles

The guanine nucleotide exchange factor DOCK5 negatively regulates osteoblast differentiation and BMP2-induced bone regeneration via the MKK3/6 and p38 signaling pathways.

Kim J, Im S, Lim J, Hong J, Ihn H, Bae J Exp Mol Med. 2024; 57(1):86-103.

PMID: 39741184 PMC: 11799167. DOI: 10.1038/s12276-024-01372-2.

TRIOBP modulates β-catenin signaling by regulation of miR-29b in idiopathic pulmonary fibrosis.

Wang L, Zhao W, Xia C, Ma S, Li Z, Wang N Cell Mol Life Sci. 2023; 81(1):13.

PMID: 38157020 PMC: 10756874. DOI: 10.1007/s00018-023-05080-4.

Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma-A Narrative Review.

Luo Y, Sun M, Tan L, Li T, Min L Pharmaceutics. 2023; 15(12).

PMID: 38140058 PMC: 10747574. DOI: 10.3390/pharmaceutics15122717.

ARAP1 negatively regulates stress fibers formation and metastasis in lung adenocarcinoma via controlling Rho signaling.

Zhang Z, Xie W, Gong B, Liang X, Yu H, Yu Y Discov Oncol. 2023; 14(1):214.

PMID: 38008882 PMC: 10678915. DOI: 10.1007/s12672-023-00832-x.

Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities.

Du X, Wei H, Zhang B, Wang B, Li Z, Pang L Front Oncol. 2023; 13:1117867.

PMID: 37197432 PMC: 10183593. DOI: 10.3389/fonc.2023.1117867.

References

Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G . Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev. 2006; 32(6):423-36. DOI: 10.1016/j.ctrv.2006.05.005. View

Tao T, Sun J, Peng Y, Wang P, Chen X, Zhao W . Distinct functions of Trio GEF domains in axon outgrowth of cerebellar granule neurons. J Genet Genomics. 2019; 46(2):87-96. DOI: 10.1016/j.jgg.2019.02.003. View

Sonoshita M, Itatani Y, Kakizaki F, Sakimura K, Terashima T, Katsuyama Y . Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO. Cancer Discov. 2014; 5(2):198-211. DOI: 10.1158/2159-8290.CD-14-0595. View

OToole T, Bialkowska K, Li X, Fox J . Tiam1 is recruited to β1-integrin complexes by 14-3-3ζ where it mediates integrin-induced Rac1 activation and motility. J Cell Physiol. 2011; 226(11):2965-78. PMC: 6385608. DOI: 10.1002/jcp.22644. View

Liu C, Ma M, Zhang J, Gui S, Zhang X, Xue S . Galangin inhibits human osteosarcoma cells growth by inducing transforming growth factor-β1-dependent osteogenic differentiation. Biomed Pharmacother. 2017; 89:1415-1421. DOI: 10.1016/j.biopha.2017.03.030. View

Lu K, Chen P, Hsieh Y, Lin C, Cheng F, Chiu P . 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo. Food Chem Toxicol. 2016; 97:177-186. DOI: 10.1016/j.fct.2016.09.006. View

Narumiya S, Tanji M, Ishizaki T . Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 2009; 28(1-2):65-76. DOI: 10.1007/s10555-008-9170-7. View

Liu C, Zhang L, Cui W, Du J, Li Z, Pang Y . Epigenetically upregulated GEFT-derived invasion and metastasis of rhabdomyosarcoma via epithelial mesenchymal transition promoted by the Rac1/Cdc42-PAK signalling pathway. EBioMedicine. 2019; 50:122-134. PMC: 6921210. DOI: 10.1016/j.ebiom.2019.10.060. View

De Craene B, Berx G . Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013; 13(2):97-110. DOI: 10.1038/nrc3447. View

10.

Guo X, Wang M, Jiang J, Xie C, Peng F, Li X . Balanced Tiam1-rac1 and RhoA drives proliferation and invasion of pancreatic cancer cells. Mol Cancer Res. 2013; 11(3):230-9. DOI: 10.1158/1541-7786.MCR-12-0632. View

11.

Reiner D, Lundquist E . Small GTPases. WormBook. 2016; 2018:1-65. PMC: 6369420. DOI: 10.1895/wormbook.1.67.2. View

12.

Otoukesh B, Boddouhi B, Moghtadaei M, Kaghazian P, Kaghazian M . Novel molecular insights and new therapeutic strategies in osteosarcoma. Cancer Cell Int. 2018; 18:158. PMC: 6192346. DOI: 10.1186/s12935-018-0654-4. View

13.

Cooke M, Baker M, Kazanietz M . Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer. Front Cell Dev Biol. 2020; 8:118. PMC: 7051914. DOI: 10.3389/fcell.2020.00118. View

14.

Ma H, Li T, Tao Z, Hai L, Tong L, Yi L . NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways. J Cell Physiol. 2018; 234(2):1630-1642. PMC: 6282979. DOI: 10.1002/jcp.27033. View

15.

Yilmaz M, Christofori G . EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009; 28(1-2):15-33. DOI: 10.1007/s10555-008-9169-0. View

16.

Gulhati P, Bowen K, Liu J, Stevens P, Rychahou P, Chen M . mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 2011; 71(9):3246-56. PMC: 3085654. DOI: 10.1158/0008-5472.CAN-10-4058. View

17.

Haydon R, Luu H, He T . Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis. Clin Orthop Relat Res. 2006; 454:237-46. DOI: 10.1097/BLO.0b013e31802b683c. View

18.

Wang S, Zhang D, Han S, Gao P, Liu C, Li J . Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway. Sci Rep. 2017; 7(1):6215. PMC: 5524709. DOI: 10.1038/s41598-017-06353-2. View

19.

Schmidt S, Debant A . Function and regulation of the Rho guanine nucleotide exchange factor Trio. Small GTPases. 2014; 5:e29769. PMC: 4114922. DOI: 10.4161/sgtp.29769. View

20.

Izumi D, Toden S, Ureta E, Ishimoto T, Baba H, Goel A . TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer. Cell Death Dis. 2019; 10(4):267. PMC: 6425043. DOI: 10.1038/s41419-019-1493-5. View